Pulmonary toxicity due to chemotherapy. How is the risk and benefit from ZD1839 treatment against non-small cell lung cancer?

Isamu Okamoto, Moritaka Suga

Research output: Contribution to journalEditorialpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)926-927
Number of pages2
JournalInternal Medicine
Issue number10
Publication statusPublished - Oct 2003

All Science Journal Classification (ASJC) codes

  • Internal Medicine

Cite this